ESTIMATED
04/26/2024
04/26/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 4 | $5.06 | $5.06 | $5.06 |
Q2 2024 | 12 | $4.74 | $5.46 | $4.92 |
Q3 2024 | 5 | $4.45 | $4.45 | $4.45 |
Q4 2024 | 5 | $6.20 | $6.20 | $6.20 |
Q1 2025 | 6 | $5.90 | $5.90 | $5.90 |
Q2 2025 | 6 | $5.61 | $5.61 | $5.61 |
Q3 2025 | 6 | $5.11 | $5.11 | $5.11 |
Q4 2025 | 6 | $6.92 | $6.92 | $6.92 |
Q1 2026 | 9 | $6.52 | $6.52 | $6.52 |
Q2 2026 | 9 | $5.89 | $5.89 | $5.89 |
Q3 2026 | 9 | $5.54 | $5.54 | $5.54 |
Q4 2026 | 9 | $7.74 | $7.74 | $7.74 |
HCA Healthcare, Inc. last posted its earnings results on Friday, April 26th, 2024. The company reported $5.93 earnings per share for the quarter, topping analysts' consensus estimates of $5.01 by $0.92. The company had revenue of 17.34 B for the quarter and had revenue of 64.97 B for the year. HCA Healthcare, Inc. has generated $19 earnings per share over the last year ($18.96 diluted earnings per share) and currently has a price-to-earnings ratio of 15.31. HCA Healthcare, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/02/2024 | Q1 2024 | $6.04 | $16.81 B | $17.34 B | 02/16/2024 | Q4 2023 | $6.05 | $16.51 B | $17.30 B | 10/26/2023 | Q3 2023 | $3.98 | $16.21 B | 08/02/2023 | Q2 2023 | $4.35 | $15.86 B | 04/27/2023 | Q1 2023 | $4.92 | $15.27 B | $15.59 B | 02/17/2023 | Q4 2022 | $7.50 | $15.63 B | $15.50 B | 11/01/2022 | Q3 2022 | $3.97 | $14.97 B | 08/01/2022 | Q2 2022 | $3.95 | $14.82 B | 05/03/2022 | Q1 2022 | $4.21 | $14.95 B | 02/18/2022 | Q4 2021 | $5.94 | $15.35 B | $15.06 B | 11/01/2021 | Q3 2021 | $7.13 | $14.53 B | $15.28 B | 08/02/2021 | Q2 2021 | $4.42 | $13.61 B | $14.44 B | 04/30/2021 | Q1 2021 | $4.21 | $13.98 B | 02/19/2021 | Q4 2020 | $4.20 | $13.99 B | $14.29 B | 10/29/2020 | Q3 2020 | $1.97 | $12.85 B | $13.31 B | 07/30/2020 | Q2 2020 | $3.19 | $10.09 B | $11.07 B | 05/06/2020 | Q1 2020 | $1.72 | $12.86 B | 02/20/2020 | Q4 2019 | $3.16 | $13.36 B | $13.52 B | 11/01/2019 | Q3 2019 | $1.80 | $12.50 B | $12.69 B | 08/02/2019 | Q2 2019 | $2.29 | $12.62 B | $12.60 B |
---|
A. HCA Healthcare, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 23rd, 2024 based off last year's report dates.
A. In the previous quarter, HCA Healthcare, Inc. (NYSE:HCA) reported $5.93 earnings per share (EPS) to beat the analysts' consensus estimate of $5.01 by $0.92.
A. The conference call for HCA Healthcare, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for HCA Healthcare, Inc.'s latest earnings report can be read online.
A. HCA Healthcare, Inc. (NYSE:HCA) has a recorded annual revenue of $64.97 B.
A. HCA Healthcare, Inc. (NYSE:HCA) has a recorded net income of $64.97 B. HCA Healthcare, Inc. has generated $19.24 earnings per share over the last four quarters.
A. HCA Healthcare, Inc. (NYSE:HCA) has a price-to-earnings ratio of 15.31 and price/earnings-to-growth ratio is 2.47.